Back to California

SB-39 • 2026

Cosmetic safety: vaginal suppositories.

Cosmetic safety: vaginal suppositories.

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Weber Pierson
Last action
2025-10-01
Official status
Chaptered by Secretary of State. Chapter 208, Statutes of 2025.
Effective date
Not listed

Plain English Breakdown

The official source material does not provide specific details on how the FDA will regulate these products or what happens if a product is sold before January 1, 2035.

Safety Rules for Vaginal Suppositories

The law extends the ban on selling vaginal suppositories with boric acid until January 1, 2035 and requires warning labels starting in 2027 if used during pregnancy or other specific conditions.

What This Bill Does

  • Extends the ban on manufacturing, selling, delivering, holding, or offering for sale any vaginal suppository containing intentionally added boric acid from January 1, 2027 to January 1, 2035.
  • Requires vaginal suppositories with boric acid to include a warning label starting in 2027 if used during pregnancy or other specified conditions.

Who It Names or Affects

  • Manufacturers and sellers of vaginal suppository products containing intentionally added boric acid
  • Consumers who use vaginal suppositories

Terms To Know

Cosmetic product
A product intended to be applied to the body for cleansing, beautifying, promoting attractiveness, or altering appearance.
Boric acid
A chemical compound used in some cosmetic products as an antiseptic and preservative.

Limits and Unknowns

  • The law does not specify what happens if a vaginal suppository with boric acid is sold before January 1, 2035.
  • It's unclear how the FDA will regulate these products or when that might happen.

Bill History

  1. 2025-10-01 California Legislative Information

    Chaptered by Secretary of State. Chapter 208, Statutes of 2025.

  2. 2025-10-01 California Legislative Information

    Approved by the Governor.

  3. 2025-09-22 California Legislative Information

    Enrolled and presented to the Governor at 11 a.m.

  4. 2025-09-11 California Legislative Information

    Assembly amendments concurred in. (Ayes 40. Noes 0. Page 2901.) Ordered to engrossing and enrolling.

  5. 2025-09-08 California Legislative Information

    In Senate. Concurrence in Assembly amendments pending.

  6. 2025-09-08 California Legislative Information

    Read third time. Urgency clause adopted. Passed. (Ayes 78. Noes 0. Page 2980.) Ordered to the Senate.

  7. 2025-09-02 California Legislative Information

    Ordered to third reading.

  8. 2025-09-02 California Legislative Information

    Read third time and amended.

  9. 2025-08-18 California Legislative Information

    Ordered to third reading.

  10. 2025-08-18 California Legislative Information

    Action rescinded whereby bill was read a third time, urgency clause adopted, passed, and ordered to the Senate.

  11. 2025-07-17 California Legislative Information

    In Assembly. Held at Desk.

  12. 2025-07-17 California Legislative Information

    Ordered to the Assembly.

  13. 2025-06-27 California Legislative Information

    In Senate. Concurrence in Assembly amendments pending.

  14. 2025-06-27 California Legislative Information

    Read third time. Urgency clause adopted. Passed. (Ayes 75. Noes 0. Page 2341.) Ordered to the Senate.

  15. 2025-06-19 California Legislative Information

    Read second time. Ordered to consent calendar.

  16. 2025-06-18 California Legislative Information

    From committee: Do pass. Ordered to consent calendar. (Ayes 7. Noes 0.) (June 17).

  17. 2025-06-12 California Legislative Information

    From committee with author's amendments. Read second time and amended. Re-referred to Com. on E.S & T.M.

  18. 2025-05-08 California Legislative Information

    From committee with author's amendments. Read second time and amended. Re-referred to Com. on E.S & T.M.

  19. 2025-04-28 California Legislative Information

    Referred to Com. on E.S & T.M.

  20. 2025-03-28 California Legislative Information

    In Assembly. Read first time. Held at Desk.

  21. 2025-03-28 California Legislative Information

    Read third time. Urgency clause adopted. Passed. (Ayes 34. Noes 0. Page 584.) Ordered to the Assembly.

  22. 2025-03-20 California Legislative Information

    Read second time. Ordered to consent calendar.

  23. 2025-03-19 California Legislative Information

    From committee: Do pass. Ordered to consent calendar. (Ayes 8. Noes 0. Page 421.) (March 19).

  24. 2025-03-03 California Legislative Information

    Set for hearing March 19.

  25. 2025-02-27 California Legislative Information

    March 5 hearing postponed by committee.

  26. 2025-02-25 California Legislative Information

    Set for hearing March 5.

  27. 2025-02-11 California Legislative Information

    From committee with author's amendments. Read second time and amended. Re-referred to Com. on E.Q.

  28. 2025-01-29 California Legislative Information

    Referred to Com. on E.Q.

  29. 2025-01-06 California Legislative Information

    Read first time.

  30. 2024-12-04 California Legislative Information

    (Corrected January 2).

  31. 2024-12-04 California Legislative Information

    From printer. May be acted upon on or after January 3.

  32. 2024-12-03 California Legislative Information

    Introduced. To Com. on RLS. for assignment. To print.

Official Summary Text

SB 39, Weber Pierson.
Cosmetic safety: vaginal suppositories.
Existing law, beginning on January 1, 2027, prohibits a person or entity from manufacturing, selling, delivering, holding, or offering for sale in commerce any cosmetic product that contains any of several specified intentionally added ingredients, including boric acid, except under specified circumstances.
This bill would extend that prohibition to January 1, 2035, for vaginal suppositories containing intentionally added boric acid. The bill would require, beginning on January 1, 2027, any vaginal suppository product containing boric acid to include a product label, as defined, warning consumers that the product should not be used during pregnancy and other specified conditions. The bill would also exempt a vaginal suppository product from the above-mentioned prohibitions if the product becomes regulated by the United States Food and Drug
Administration.
The bill would make related findings and declarations.
This bill would incorporate additional changes to Section 108980 of the Health and Safety Code proposed by AB 60 to be operative only if this bill and AB 60 are enacted and this bill is enacted last.
This bill would declare that it is to take effect immediately as an urgency statute.

Current Bill Text

Read the full stored bill text
Download Bill PDF